Structure-activity relationship study of novel peptoids that mimic the structure of antimicrobial peptides

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 7, 2015, Pages 4112-4120

  Mojsoska, Biljana ^a   Zuckermann, Ronald N ^b   Jenssen, Håvard ^a  

^a ROSKILDE UNIVERSITY   (Denmark)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BAC 8C; INDOLICIDIN; OMIGANAN; PEPTOID; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; PEPTIDE;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG STRUCTURE; ERYTHROCYTE; ESCHERICHIA COLI; FEMALE; HELA CELL LINE; HUMAN; HUMAN CELL; HYDROPHOBICITY; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; HEMOLYSIS; MICROBIAL SENSITIVITY TEST;

ANTI-BACTERIAL AGENTS; CELL SURVIVAL; ERYTHROCYTES; ESCHERICHIA COLI; HELA CELLS; HEMOLYSIS; HUMANS; MICROBIAL SENSITIVITY TESTS; PEPTIDES; PEPTOIDS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84935900157     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00237-15     Document Type: Article

References (38)

1. Jenssen H, Hamill P, Hancock RE. 2006. Peptide antimicrobial agents. Clin Microbiol Rev 19:491-511. http://dx.doi.org/10.1128/CMR.00056-05.
2. Tan NC, Yu P, Kwon YU, Kodadek T. 2008. High-throughput evaluation of relative cell permeability between peptoids and peptides. Bioorg Med Chem 16:5853-5861. http://dx.doi.org/10.1016/j.bmc.2008.04.074.
3. Bang JK, Hai Y, Lee EK, Shin SY. 2010. A novel Trp-rich model antimicrobial peptide with increased protease stability. Bull Korean Chem Soc 31:2509-2513. http://dx.doi.org/10.5012/bkcs.2010.31.9.2509.
4. Miller SM, Simon RJ, Ng S, Zuckermann RN, Kerr JM, Moos WH. 1994. Proteolytic studies of homologous peptide and N-substituted glycine peptoid oligomers. Bioorg Med Chem Lett 4:2657-2662. http://dx.doi.org/10.1016/S0960-894X(01)80691-0.
5. Chongsiriwatana NP, Patch JA, Czyzewski AM, Dohm MT, Ivankin A, Gidalevitz D, Zuckermann RN, Barron AE. 2008. Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides. Proc Natl Acad Sci U S A 105:2794-2799. http://dx.doi.org/10.1073/pnas.0708254105.
6. Ghosh C, Manjunath GB, Akkapeddi P, Yarlagadda V, Hoque J, Uppu DS, Konai MM, Haldar J. 2014. Small molecular antibacterial peptoid mimics: the simpler the better! J Med Chem 57:1428-1436. http://dx.doi.org/10.1021/jm401680a.
7. Godballe T, Nilsson LL, Petersen PD, Jenssen H. 2011. Antimicrobial beta-peptides and alpha-peptoids. Chem Biol Drug Des 77:107-116. http: //dx.doi.org/10.1111/j.1747-0285.2010.01067.x.
8. Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB. 2000. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc Natl Acad Sci U S A 97:13003-13008. http://dx.doi.org/10.1073/pnas.97.24.13003.
9. Murphy JE, Uno T, Hamer JD, Cohen FE, Dwarki V, Zuckermann RN. 1998. A combinatorial approach to the discovery of efficient cationic peptoid reagents for gene delivery. Proc Natl Acad Sci U S A 95:1517-1522. http://dx.doi.org/10.1073/pnas.95.4.1517.
10. Huang W, Seo J, Willingham SB, Czyzewski AM, Gonzalgo ML, Weissman IL, Barron AE. 2014. Learning from host-defense peptides: cationic, amphipathic peptoids with potent anticancer activity. PLoS One 9:e90397. http://dx.doi.org/10.1371/journal.pone.0090397.
11. Olivier GK, Cho A, Sanii B, Connolly MD, Tran H, Zuckermann RN. 2013. Antibody-mimetic peptoid nanosheets for molecular recognition. ACS Nano 7:9276-9286. http://dx.doi.org/10.1021/nn403899y.
12. Olivier G, Proulx C, Zuckermann R. 2013. Functionalized peptoid nano-sheets. Abstracts of papers of the American Chemical Society, vol 246. American Chemical Society, Washington, DC.
13. Chen YX, Guarnieri MT, Vasil AI, Vasil ML, Mant CT, Hodges RS. 2007. Role of peptide hydrophobicity in the mechanism of action of alphahelical antimicrobial peptides. Antimicrob Agents Chemother 51:1398-1406. http://dx.doi.org/10.1128/AAC.00925-06.
14. Thaker HD, Cankaya A, Scott RW, Tew GN. 2013. Role of amphiphilicity in the design of synthetic mimics of antimicrobial peptides with Gram-negative activity. ACS Med Chem Lett 4:481-485. http://dx.doi.org /10.1021/ml300307b.
15. Park Y, Kim HN, Park SN, Jang SH, Choi CH, Lim HT, Hahm KS. 2004. Design of novel analogues with potent antibiotic activity based on the antimicrobial peptide, HP(2-9)-ME(1-12). Biotechnol Lett 26:493-498. http://dx.doi.org/10.1023/B:BILE.0000019556.79703.4b.
16. Blondelle SE, Houghten RA. 1992. Design of model amphipathic peptides having potent antimicrobial activities. Biochemistry 31:12688-12694. http://dx.doi.org/10.1021/bi00165a020.
17. Brogden KA. 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3:238-250. http://dx.doi.org/10.1038/nrmicro1098.
18. Patch JA, Barron AE. 2003. Helical peptoid mimics of magainin-2 amide. J Am Chem Soc 125:12092-12093. http://dx.doi.org/10.1021/ja037320d.
19. Fjell CD, Jenssen H, Hilpert K, Cheung WA, Pante N, Hancock REW, Cherkasov A. 2009. Identification of novel antibacterial peptides by chemoinformatics and machine learning. J Med Chem 52:2006-2015. http: //dx.doi.org/10.1021/jm8015365.
20. Figliozzi GM, Goldsmith R, Ng SC, Banville SC, Zuckermann RN. 1996. Synthesis of N-substituted glycine peptoid libraries. Methods Enzymol 267:437-447. http://dx.doi.org/10.1016/S0076-6879(96)67027-X.
21. Wiegand I, Hilpert K, Hancock RE. 2008. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 3:163-175. http://dx.doi.org/10.1038/nprot.2007.521.
22. Fjell CD, Jenssen H, Cheung WA, Hancock RE, Cherkasov A. 2011. Optimization of antibacterial peptides by genetic algorithms and chemin-formatics. Chem Biol Drug Des 77:48-56. http://dx.doi.org/10.1111/j.1747-0285.2010.01044.x.
23. Cherkasov A, Hilpert K, Jenssen H, Fjell CD, Waldbrook M, Mullaly SC, Volkmer R, Hancock REW. 2009. Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs. ACS Chem Biol 4:65-74. http://dx.doi.org/10.1021/cb800240j.
24. Ryge TS, Hansen PR. 2005. Novel lysine-peptoid hybrids with antibacterial properties. J Pept Sci 11:727-734. http://dx.doi.org/10.1002/psc.705.
25. Gopal R, Seo CH, Song PI, Park Y. 2013. Effect of repetitive lysine-tryptophan motifs on the bactericidal activity of antimicrobial peptides. Amino Acids 44:645-660. http://dx.doi.org/10.1007/s00726-012-1388-6.
26. de Leeuw E, Rajabi M, Zou G, Pazgier M, Lu W. 2009. Selective arginines are important for the antibacterial activity and host cell interaction of human alpha-defensin 5. FEBS Lett 583:2507-2512. http://dx.doi.org/10.1016/j.febslet.2009.06.051.
27. Strøm MB, Haug BE, Skar ML, Stensen W, Stiberg T, Svendsen JS. 2003. The pharmacophore of short cationic antibacterial peptides. J Med Chem 46:1567-1570. http://dx.doi.org/10.1021/jm0340039.
28. McPhee JB, Scott MG, Hancock RE. 2005. Design of host defence peptides for antimicrobial and immunity enhancing activities. Comb Chem High Throughput Screen 8:257-272. http://dx.doi.org/10.2174 /1386207053764558.
29. Zelezetsky I, Tossi A. 2006. Alpha-helical antimicrobial peptides - using a sequence template to guide structure-activity relationship studies. Biochim Biophys Acta 1758:1436-1449. http://dx.doi.org/10.1016/j.bbamem.2006.03.021.
30. Wieprecht T, Dathe M, Krause E, Beyermann M, Maloy WL, Mac-Donald DL, Bienert M. 1997. Modulation of membrane activity of amphipathic, antibacterial peptides by slight modifications of the hydrophobic moment. FEBS Lett 417:135-140. http://dx.doi.org/10.1016 /S0014-5793(97)01266-0.
31. Fernández-Vidal M, Jayasinghe S, Ladokhin AS, White SH. 2007. Folding amphipathic helices into membranes: amphiphilicity trumps hydrophobicity. J Mol Biol 370:459-470. http://dx.doi.org/10.1016/j.jmb.2007.05.016.
32. Tyagi A, Kapoor P, Kumar R, Chaudhary K, Gautam A, Raghava GP. 2013. In silico models for designing and discovering novel anticancer peptides. Sci Rep 3:2984. http://dx.doi.org/10.1038/srep02984.
33. Wimley WC. 2010. Describing the mechanism of antimicrobial peptide action with the interfacial activity model. ACS Chem Biol 5:905-917. http: //dx.doi.org/10.1021/cb1001558.
34. Mihajlovic M, Lazaridis T. 2012. Charge distribution and imperfect amphipathicity affect pore formation by antimicrobial peptides. Biochim Biophys Acta 1818:1274-1283. http://dx.doi.org/10.1016/j.bbamem.2012.01.016.
35. Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS. 2005. Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J Biol Chem 280: 12316-12329. http://dx.doi.org/10.1074/jbc.M413406200.
36. Fisher LM, Lawrence JM, Josty IC, Hopewell R, Margerrison EEC, Cullen ME. 1989. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance. Am J Med 87:S2-S8. http://dx.doi.org/10.1016/0002-9343(89)90010-7.
37. Chan DI, Prenner EJ, Vogel HJ. 2006. Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanisms of action. Biochim Biophys Acta 1758:1184-1202. http://dx.doi.org/10.1016/j.bbamem.2006.04.006.
38. Jahnsen RD, Sandberg-Schaal A, Vissing KJ, Nielsen HM, Frimodt-Møller N, Franzyk H. 2014. Tailoring cytotoxicity of antimicrobial peptidomimetics with high activity against multidrug-resistant Escherichia coli. J Med Chem 57:2864-2873. http://dx.doi.org/10.1021/jm401335p.